You are here » Home » Companies » Company Overview » Aurobindo Pharma Ltd

Aurobindo Pharma Ltd.

BSE: 524804	Sector: Health care
NSE: AUROPHARMA	ISIN Code: INE406A01037

BSE 00:00 | 20 May

557.85

34.95
(6.68%)

OPEN

524.50

HIGH

559.80

LOW

524.05

NSE 00:00 | 20 May

557.95

35.10
(6.71%)

OPEN

523.00

HIGH

559.65

LOW

523.00

Add to Watchlist | Add to Portfolio

OPEN	524.50
PREVIOUS CLOSE	522.90
VOLUME	270164
52-Week high	1043.00
52-Week low	521.00
P/E	21.43
Mkt Cap.(Rs cr)	32,684
Buy Price	0.00
Buy Qty	0.00
Sell Price	0.00
Sell Qty	0.00

OPEN	524.50
CLOSE	522.90
VOLUME	270164
52-Week high	1043.00
52-Week low	521.00
P/E	21.43
Mkt Cap.(Rs cr)	32,684
Buy Price	0.00
Buy Qty	0.00
Sell Price	0.00
Sell Qty	0.00

Aurobindo Pharma Ltd. (AUROPHARMA) - Latest News & Headlines

Aurobindo hits 2-year low; dips 11% in a week on USFDA's 6 observations

12.42 pm | 17 May 2022 | Business Standard

Analysts at ICICI Securities expect Aurobindo Pharma's adjusted PAT to de-grow 30.4 per cent year-on-year (YoY) to Rs 557.90 crore in the March 2022 q...
Aurobindo's Veritaz acquisition unlikely to add much value: Analysts

4.42 pm | 29 Mar 2022 | Business Standard

Deal is nonetheless a stepping stone in the drug firm's strategic plan to focus on domestic formulations market, where it aims to have Rs 1,000-cr sal...
Aurobindo Pharma acquires Veritaz' domestic business for Rs 171 cr

12.18 am | 29 Mar 2022 | Business Standard

Move marks Aurobindo's increasing focus on Indian market
Nifty Pharma may have bottomed out; Aurobindo, Glenmark can rally up to 10%

12.54 pm | 21 Mar 2022 | Business Standard

The Nifty Pharma index has crossed its near-term resistance at 13,700, and may spurt another 1.5 per cent.
Select pharma shares gain on tie-up for Pfizer Covid-19 oral treatment drug

12.29 pm | 21 Mar 2022 | Business Standard

Among individual stocks, Aurobindo Pharma was the top gainer, which rallied 8 per cent to Rs 688.90 on the BSE in intra-day trade.
Aurobindo Pharma net profit dips 22% to Rs 604 cr in December quarter

8.04 pm | 9 Feb 2022 | Press Trust of India

The Hyderabad-based drug maker had reported a consolidated net profit of Rs 777.3 crore in the same period of previous fiscal
Aurobindo Pharma down 5% on USFDA warning letter for Hyderabad unit

1.05 am | 15 Jan 2022 | Business Standard

The company believes that this will not impact the existing business from this facility.
Stocks to Watch: Hero MotoCorp, Aurobindo, Neogen, SPARC, telecom shares

7.41 am | 6 Dec 2021 | Business Standard

Telecom shares may be in demand on credit of bank guarantee to the telcos
Hero MotoCorp, Lupin, Colgate, Aurobindo, Amara Raja hit 52-week lows

3.11 pm | 22 Nov 2021 | Business Standard

In past four trading days, the S&P BSE Sensex has tanked 4 per cent or 2,412 points on concerns about European Covid-19 curbs and on risk of the US Fe...